Additionally, ANGPTL4 mediates tumor proliferation and metastasis through metabolic pathways in both dyslipidemia-associated CRC and F. nucleatum-related CRC [19, 20]. The gene discussed is ANGPTL4; the disease is metabolic syndrome.